Cargando…

Incidence and survival of head and neck cancer in the Faroe Islands

Background: The Faroese people constitute a geographically isolated population, and research on cancer in this population is sparse. Thus, this study aimed to calculate the age-standardised incidence rate (ASIR) and 5-year survival rates in head and neck cancers (HNC) in the Faroese population from...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsen, Sunnvá Hanusardóttir, Friborg, Jeppe, Ellefsen, Bjarki, Jakobsen, Kathrine Kronberg, Aanæs, Kasper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971248/
https://www.ncbi.nlm.nih.gov/pubmed/33719929
http://dx.doi.org/10.1080/22423982.2021.1894697
_version_ 1783666576391667712
author Olsen, Sunnvá Hanusardóttir
Friborg, Jeppe
Ellefsen, Bjarki
Jakobsen, Kathrine Kronberg
Aanæs, Kasper
author_facet Olsen, Sunnvá Hanusardóttir
Friborg, Jeppe
Ellefsen, Bjarki
Jakobsen, Kathrine Kronberg
Aanæs, Kasper
author_sort Olsen, Sunnvá Hanusardóttir
collection PubMed
description Background: The Faroese people constitute a geographically isolated population, and research on cancer in this population is sparse. Thus, this study aimed to calculate the age-standardised incidence rate (ASIR) and 5-year survival rates in head and neck cancers (HNC) in the Faroese population from 1985 to 2017. Materials and methods: All patients registered with HNC in the Faroese Cancer Registry (FCR) from 1985 to 2017 were included. The ASIR per 100,000 (World Standard Population) and 5-year survival rates were calculated. We also calculated the distribution of tobacco, alcohol consumption, cancer stages and various timelines.  Results: 202 patients were included in the study (62% men). The ASIR for all HNC was 10.0/100,000 persons-years and was higher among men than women. Women’s survival rate was significantly higher than men’s (p = 0.026). The results imply that oropharyngeal cancer (OPC) had the best survival rate and was diagnosed at a significantly earlier stage. Conclusion: This retrospective nation-wide study showed that ASIRs and 5-year survival rates for Faroese HNC patients in general resembled the ones reported for Danish HNC patients. Timelines for Faroese HNC patients were shorter compared with Greenlandic HNC patients, but longer compared with the Danish fast track programme limits.
format Online
Article
Text
id pubmed-7971248
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-79712482021-03-31 Incidence and survival of head and neck cancer in the Faroe Islands Olsen, Sunnvá Hanusardóttir Friborg, Jeppe Ellefsen, Bjarki Jakobsen, Kathrine Kronberg Aanæs, Kasper Int J Circumpolar Health Original Research Article Background: The Faroese people constitute a geographically isolated population, and research on cancer in this population is sparse. Thus, this study aimed to calculate the age-standardised incidence rate (ASIR) and 5-year survival rates in head and neck cancers (HNC) in the Faroese population from 1985 to 2017. Materials and methods: All patients registered with HNC in the Faroese Cancer Registry (FCR) from 1985 to 2017 were included. The ASIR per 100,000 (World Standard Population) and 5-year survival rates were calculated. We also calculated the distribution of tobacco, alcohol consumption, cancer stages and various timelines.  Results: 202 patients were included in the study (62% men). The ASIR for all HNC was 10.0/100,000 persons-years and was higher among men than women. Women’s survival rate was significantly higher than men’s (p = 0.026). The results imply that oropharyngeal cancer (OPC) had the best survival rate and was diagnosed at a significantly earlier stage. Conclusion: This retrospective nation-wide study showed that ASIRs and 5-year survival rates for Faroese HNC patients in general resembled the ones reported for Danish HNC patients. Timelines for Faroese HNC patients were shorter compared with Greenlandic HNC patients, but longer compared with the Danish fast track programme limits. Taylor & Francis 2021-03-14 /pmc/articles/PMC7971248/ /pubmed/33719929 http://dx.doi.org/10.1080/22423982.2021.1894697 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Article
Olsen, Sunnvá Hanusardóttir
Friborg, Jeppe
Ellefsen, Bjarki
Jakobsen, Kathrine Kronberg
Aanæs, Kasper
Incidence and survival of head and neck cancer in the Faroe Islands
title Incidence and survival of head and neck cancer in the Faroe Islands
title_full Incidence and survival of head and neck cancer in the Faroe Islands
title_fullStr Incidence and survival of head and neck cancer in the Faroe Islands
title_full_unstemmed Incidence and survival of head and neck cancer in the Faroe Islands
title_short Incidence and survival of head and neck cancer in the Faroe Islands
title_sort incidence and survival of head and neck cancer in the faroe islands
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971248/
https://www.ncbi.nlm.nih.gov/pubmed/33719929
http://dx.doi.org/10.1080/22423982.2021.1894697
work_keys_str_mv AT olsensunnvahanusardottir incidenceandsurvivalofheadandneckcancerinthefaroeislands
AT friborgjeppe incidenceandsurvivalofheadandneckcancerinthefaroeislands
AT ellefsenbjarki incidenceandsurvivalofheadandneckcancerinthefaroeislands
AT jakobsenkathrinekronberg incidenceandsurvivalofheadandneckcancerinthefaroeislands
AT aanæskasper incidenceandsurvivalofheadandneckcancerinthefaroeislands